Global Deferiprone Market Growth 2025-2031

March 2025 | 83 pages | ID: GF7B3345EE4EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Deferiprone market size is predicted to grow from US$ 38.7 million in 2025 to US$ 47.4 million in 2031; it is expected to grow at a CAGR of 3.4% from 2025 to 2031.

Deferiprone is an orally bioavailable bidentate ligand with iron chelating activity.1 It binds to iron in a 3:1 (ligand:iron) molar ratio and, thereby, is able to remove excess iron from the body. Deferiprone has been investigated for clinical use in diseases of systemic iron overload.

Apotex, Cipla and other company are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. Those two totally got about 96% market shares.

North America is the largest consumption region of Deferiprone, with a consumption value market share nearly 28%. Europe is the second largest consumption region of deferiprone, enjoying consumption value market share nearly 24%.

LP Information, Inc. (LPI) ' newest research report, the “Deferiprone Industry Forecast” looks at past sales and reviews total world Deferiprone sales in 2024, providing a comprehensive analysis by region and market sector of projected Deferiprone sales for 2025 through 2031. With Deferiprone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Deferiprone industry.

This Insight Report provides a comprehensive analysis of the global Deferiprone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Deferiprone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Deferiprone market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Deferiprone and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Deferiprone.

This report presents a comprehensive overview, market shares, and growth opportunities of Deferiprone market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Tablet
• Oral Solution
• Capsule

Segmentation by Application:

• Transfusional Iron Overload
• NTDT Caused Iron Overload

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Apotex
• Cipla

Key Questions Addressed in this Report

What is the 10-year outlook for the global Deferiprone market?

What factors are driving Deferiprone market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Deferiprone market opportunities vary by end market size?

How does Deferiprone break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Deferiprone Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Deferiprone by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Deferiprone by Country/Region, 2020, 2024 & 2031
2.2 Deferiprone Segment by Type
  2.2.1 Tablet
  2.2.2 Oral Solution
  2.2.3 Capsule
2.3 Deferiprone Sales by Type
  2.3.1 Global Deferiprone Sales Market Share by Type (2020-2025)
  2.3.2 Global Deferiprone Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Deferiprone Sale Price by Type (2020-2025)
2.4 Deferiprone Segment by Application
  2.4.1 Transfusional Iron Overload
  2.4.2 NTDT Caused Iron Overload
2.5 Deferiprone Sales by Application
  2.5.1 Global Deferiprone Sale Market Share by Application (2020-2025)
  2.5.2 Global Deferiprone Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Deferiprone Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Deferiprone Breakdown Data by Company
  3.1.1 Global Deferiprone Annual Sales by Company (2020-2025)
  3.1.2 Global Deferiprone Sales Market Share by Company (2020-2025)
3.2 Global Deferiprone Annual Revenue by Company (2020-2025)
  3.2.1 Global Deferiprone Revenue by Company (2020-2025)
  3.2.2 Global Deferiprone Revenue Market Share by Company (2020-2025)
3.3 Global Deferiprone Sale Price by Company
3.4 Key Manufacturers Deferiprone Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Deferiprone Product Location Distribution
  3.4.2 Players Deferiprone Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR DEFERIPRONE BY GEOGRAPHIC REGION

4.1 World Historic Deferiprone Market Size by Geographic Region (2020-2025)
  4.1.1 Global Deferiprone Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Deferiprone Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Deferiprone Market Size by Country/Region (2020-2025)
  4.2.1 Global Deferiprone Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Deferiprone Annual Revenue by Country/Region (2020-2025)
4.3 Americas Deferiprone Sales Growth
4.4 APAC Deferiprone Sales Growth
4.5 Europe Deferiprone Sales Growth
4.6 Middle East & Africa Deferiprone Sales Growth

5 AMERICAS

5.1 Americas Deferiprone Sales by Country
  5.1.1 Americas Deferiprone Sales by Country (2020-2025)
  5.1.2 Americas Deferiprone Revenue by Country (2020-2025)
5.2 Americas Deferiprone Sales by Type (2020-2025)
5.3 Americas Deferiprone Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Deferiprone Sales by Region
  6.1.1 APAC Deferiprone Sales by Region (2020-2025)
  6.1.2 APAC Deferiprone Revenue by Region (2020-2025)
6.2 APAC Deferiprone Sales by Type (2020-2025)
6.3 APAC Deferiprone Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Deferiprone by Country
  7.1.1 Europe Deferiprone Sales by Country (2020-2025)
  7.1.2 Europe Deferiprone Revenue by Country (2020-2025)
7.2 Europe Deferiprone Sales by Type (2020-2025)
7.3 Europe Deferiprone Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Deferiprone by Country
  8.1.1 Middle East & Africa Deferiprone Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Deferiprone Revenue by Country (2020-2025)
8.2 Middle East & Africa Deferiprone Sales by Type (2020-2025)
8.3 Middle East & Africa Deferiprone Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Deferiprone
10.3 Manufacturing Process Analysis of Deferiprone
10.4 Industry Chain Structure of Deferiprone

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Deferiprone Distributors
11.3 Deferiprone Customer

12 WORLD FORECAST REVIEW FOR DEFERIPRONE BY GEOGRAPHIC REGION

12.1 Global Deferiprone Market Size Forecast by Region
  12.1.1 Global Deferiprone Forecast by Region (2026-2031)
  12.1.2 Global Deferiprone Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Deferiprone Forecast by Type (2026-2031)
12.7 Global Deferiprone Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Apotex
  13.1.1 Apotex Company Information
  13.1.2 Apotex Deferiprone Product Portfolios and Specifications
  13.1.3 Apotex Deferiprone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Apotex Main Business Overview
  13.1.5 Apotex Latest Developments
13.2 Cipla
  13.2.1 Cipla Company Information
  13.2.2 Cipla Deferiprone Product Portfolios and Specifications
  13.2.3 Cipla Deferiprone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Cipla Main Business Overview
  13.2.5 Cipla Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Deferiprone Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Deferiprone Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Tablet
Table 4. Major Players of Oral Solution
Table 5. Major Players of Capsule
Table 6. Global Deferiprone Sales by Type (2020-2025) & (Kg)
Table 7. Global Deferiprone Sales Market Share by Type (2020-2025)
Table 8. Global Deferiprone Revenue by Type (2020-2025) & ($ million)
Table 9. Global Deferiprone Revenue Market Share by Type (2020-2025)
Table 10. Global Deferiprone Sale Price by Type (2020-2025) & (USD/g)
Table 11. Global Deferiprone Sale by Application (2020-2025) & (Kg)
Table 12. Global Deferiprone Sale Market Share by Application (2020-2025)
Table 13. Global Deferiprone Revenue by Application (2020-2025) & ($ million)
Table 14. Global Deferiprone Revenue Market Share by Application (2020-2025)
Table 15. Global Deferiprone Sale Price by Application (2020-2025) & (USD/g)
Table 16. Global Deferiprone Sales by Company (2020-2025) & (Kg)
Table 17. Global Deferiprone Sales Market Share by Company (2020-2025)
Table 18. Global Deferiprone Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Deferiprone Revenue Market Share by Company (2020-2025)
Table 20. Global Deferiprone Sale Price by Company (2020-2025) & (USD/g)
Table 21. Key Manufacturers Deferiprone Producing Area Distribution and Sales Area
Table 22. Players Deferiprone Products Offered
Table 23. Deferiprone Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Deferiprone Sales by Geographic Region (2020-2025) & (Kg)
Table 27. Global Deferiprone Sales Market Share Geographic Region (2020-2025)
Table 28. Global Deferiprone Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Deferiprone Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Deferiprone Sales by Country/Region (2020-2025) & (Kg)
Table 31. Global Deferiprone Sales Market Share by Country/Region (2020-2025)
Table 32. Global Deferiprone Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Deferiprone Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Deferiprone Sales by Country (2020-2025) & (Kg)
Table 35. Americas Deferiprone Sales Market Share by Country (2020-2025)
Table 36. Americas Deferiprone Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Deferiprone Sales by Type (2020-2025) & (Kg)
Table 38. Americas Deferiprone Sales by Application (2020-2025) & (Kg)
Table 39. APAC Deferiprone Sales by Region (2020-2025) & (Kg)
Table 40. APAC Deferiprone Sales Market Share by Region (2020-2025)
Table 41. APAC Deferiprone Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Deferiprone Sales by Type (2020-2025) & (Kg)
Table 43. APAC Deferiprone Sales by Application (2020-2025) & (Kg)
Table 44. Europe Deferiprone Sales by Country (2020-2025) & (Kg)
Table 45. Europe Deferiprone Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Deferiprone Sales by Type (2020-2025) & (Kg)
Table 47. Europe Deferiprone Sales by Application (2020-2025) & (Kg)
Table 48. Middle East & Africa Deferiprone Sales by Country (2020-2025) & (Kg)
Table 49. Middle East & Africa Deferiprone Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Deferiprone Sales by Type (2020-2025) & (Kg)
Table 51. Middle East & Africa Deferiprone Sales by Application (2020-2025) & (Kg)
Table 52. Key Market Drivers & Growth Opportunities of Deferiprone
Table 53. Key Market Challenges & Risks of Deferiprone
Table 54. Key Industry Trends of Deferiprone
Table 55. Deferiprone Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Deferiprone Distributors List
Table 58. Deferiprone Customer List
Table 59. Global Deferiprone Sales Forecast by Region (2026-2031) & (Kg)
Table 60. Global Deferiprone Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Deferiprone Sales Forecast by Country (2026-2031) & (Kg)
Table 62. Americas Deferiprone Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Deferiprone Sales Forecast by Region (2026-2031) & (Kg)
Table 64. APAC Deferiprone Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Deferiprone Sales Forecast by Country (2026-2031) & (Kg)
Table 66. Europe Deferiprone Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Deferiprone Sales Forecast by Country (2026-2031) & (Kg)
Table 68. Middle East & Africa Deferiprone Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Deferiprone Sales Forecast by Type (2026-2031) & (Kg)
Table 70. Global Deferiprone Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Deferiprone Sales Forecast by Application (2026-2031) & (Kg)
Table 72. Global Deferiprone Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Apotex Basic Information, Deferiprone Manufacturing Base, Sales Area and Its Competitors
Table 74. Apotex Deferiprone Product Portfolios and Specifications
Table 75. Apotex Deferiprone Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 76. Apotex Main Business
Table 77. Apotex Latest Developments
Table 78. Cipla Basic Information, Deferiprone Manufacturing Base, Sales Area and Its Competitors
Table 79. Cipla Deferiprone Product Portfolios and Specifications
Table 80. Cipla Deferiprone Sales (Kg), Revenue ($ Million), Price (USD/g) and Gross Margin (2020-2025)
Table 81. Cipla Main Business
Table 82. Cipla Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Deferiprone
Figure 2. Deferiprone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Deferiprone Sales Growth Rate 2020-2031 (Kg)
Figure 7. Global Deferiprone Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Deferiprone Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Deferiprone Sales Market Share by Country/Region (2024)
Figure 10. Deferiprone Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Tablet
Figure 12. Product Picture of Oral Solution
Figure 13. Product Picture of Capsule
Figure 14. Global Deferiprone Sales Market Share by Type in 2025
Figure 15. Global Deferiprone Revenue Market Share by Type (2020-2025)
Figure 16. Deferiprone Consumed in Transfusional Iron Overload
Figure 17. Global Deferiprone Market: Transfusional Iron Overload (2020-2025) & (Kg)
Figure 18. Deferiprone Consumed in NTDT Caused Iron Overload
Figure 19. Global Deferiprone Market: NTDT Caused Iron Overload (2020-2025) & (Kg)
Figure 20. Global Deferiprone Sale Market Share by Application (2024)
Figure 21. Global Deferiprone Revenue Market Share by Application in 2025
Figure 22. Deferiprone Sales by Company in 2025 (Kg)
Figure 23. Global Deferiprone Sales Market Share by Company in 2025
Figure 24. Deferiprone Revenue by Company in 2025 ($ millions)
Figure 25. Global Deferiprone Revenue Market Share by Company in 2025
Figure 26. Global Deferiprone Sales Market Share by Geographic Region (2020-2025)
Figure 27. Global Deferiprone Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Deferiprone Sales 2020-2025 (Kg)
Figure 29. Americas Deferiprone Revenue 2020-2025 ($ millions)
Figure 30. APAC Deferiprone Sales 2020-2025 (Kg)
Figure 31. APAC Deferiprone Revenue 2020-2025 ($ millions)
Figure 32. Europe Deferiprone Sales 2020-2025 (Kg)
Figure 33. Europe Deferiprone Revenue 2020-2025 ($ millions)
Figure 34. Middle East & Africa Deferiprone Sales 2020-2025 (Kg)
Figure 35. Middle East & Africa Deferiprone Revenue 2020-2025 ($ millions)
Figure 36. Americas Deferiprone Sales Market Share by Country in 2025
Figure 37. Americas Deferiprone Revenue Market Share by Country (2020-2025)
Figure 38. Americas Deferiprone Sales Market Share by Type (2020-2025)
Figure 39. Americas Deferiprone Sales Market Share by Application (2020-2025)
Figure 40. United States Deferiprone Revenue Growth 2020-2025 ($ millions)
Figure 41. Canada Deferiprone Revenue Growth 2020-2025 ($ millions)
Figure 42. Mexico Deferiprone Revenue Growth 2020-2025 ($ millions)
Figure 43. Brazil Deferiprone Revenue Growth 2020-2025 ($ millions)
Figure 44. APAC Deferiprone Sales Market Share by Region in 2025
Figure 45. APAC Deferiprone Revenue Market Share by Region (2020-2025)
Figure 46. APAC Deferiprone Sales Market Share by Type (2020-2025)
Figure 47. APAC Deferiprone Sales Market Share by Application (2020-2025)
Figure 48. China Deferiprone Revenue Growth 2020-2025 ($ millions)
Figure 49. Japan Deferiprone Revenue Growth 2020-2025 ($ millions)
Figure 50. South Korea Deferiprone Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast Asia Deferiprone Revenue Growth 2020-2025 ($ millions)
Figure 52. India Deferiprone Revenue Growth 2020-2025 ($ millions)
Figure 53. Australia Deferiprone Revenue Growth 2020-2025 ($ millions)
Figure 54. China Taiwan Deferiprone Revenue Growth 2020-2025 ($ millions)
Figure 55. Europe Deferiprone Sales Market Share by Country in 2025
Figure 56. Europe Deferiprone Revenue Market Share by Country (2020-2025)
Figure 57. Europe Deferiprone Sales Market Share by Type (2020-2025)
Figure 58. Europe Deferiprone Sales Market Share by Application (2020-2025)
Figure 59. Germany Deferiprone Revenue Growth 2020-2025 ($ millions)
Figure 60. France Deferiprone Revenue Growth 2020-2025 ($ millions)
Figure 61. UK Deferiprone Revenue Growth 2020-2025 ($ millions)
Figure 62. Italy Deferiprone Revenue Growth 2020-2025 ($ millions)
Figure 63. Russia Deferiprone Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & Africa Deferiprone Sales Market Share by Country (2020-2025)
Figure 65. Middle East & Africa Deferiprone Sales Market Share by Type (2020-2025)
Figure 66. Middle East & Africa Deferiprone Sales Market Share by Application (2020-2025)
Figure 67. Egypt Deferiprone Revenue Growth 2020-2025 ($ millions)
Figure 68. South Africa Deferiprone Revenue Growth 2020-2025 ($ millions)
Figure 69. Israel Deferiprone Revenue Growth 2020-2025 ($ millions)
Figure 70. Turkey Deferiprone Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC Countries Deferiprone Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Deferiprone in 2025
Figure 73. Manufacturing Process Analysis of Deferiprone
Figure 74. Industry Chain Structure of Deferiprone
Figure 75. Channels of Distribution
Figure 76. Global Deferiprone Sales Market Forecast by Region (2026-2031)
Figure 77. Global Deferiprone Revenue Market Share Forecast by Region (2026-2031)
Figure 78. Global Deferiprone Sales Market Share Forecast by Type (2026-2031)
Figure 79. Global Deferiprone Revenue Market Share Forecast by Type (2026-2031)
Figure 80. Global Deferiprone Sales Market Share Forecast by Application (2026-2031)
Figure 81. Global Deferiprone Revenue Market Share Forecast by Application (2026-2031)